Your Health, We Care
Dabrafenib and its combination therapy have gained widespread attention and recognition in the market, becoming one of the important drugs for treating BRAF V600E mutant tumors. With the development of precision medicine, more and more patients have been diagnosed with BRAF V600E mutation through genetic testing and are receiving treatment with Dabrafenib and its combination therapy.
At present, several internationally renowned pharmaceutical companies and medical institutions have established in-depth cooperation with the FDA in the research and application of Dabrafenib and its combination therapies, jointly promoting the development of personalized treatment.
Scan code
Whatsapp
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
